Tools for Active Safety Surveillance of Maternal and Infant Health Outcomes for Pregnant and Breastfeeding Users of Oral PrEP and PrEP Ring
The WHO Implementation Tool for Monitoring the Toxicity of New Antiretroviral and Antiviral Medicines in HIV and Viral Hepatitis Programmes provides a framework for pharmacovigilance monitoring within the context of national treatment programs. Although this framework allows for inclusion of pregnant women, it does not include surveillance of many important maternal and child health outcomes. The surveillance tools included in this package, including a PBFP PrEP Surveillance Register and a PBFP PrEP Case Report Form are meant to serve as templates for countries to adapt to fit their own surveillance systems.
Resource Details
- Resource Category
- Policy & Guidelines
- Document Type
- M&E Tool
- Year
- 2023
- Population
- PBFW Focused Resource
- Source
- MOSAIC/PrEP Watch
More Resources
Standard Operating Procedure for Injectable Lenacapavir as Pre-exposure Prophylaxis
Provider Training Toolkit on Use of Oral and Long Acting HIV PrEP
Site/Facility Readiness Assessment Tool to Support Lenacapavir for HIV Prevention Introduction
Rapid Landscape Analysis of National Vertical Transmission Policies for Inclusion of PrEP for Pregnant and Breastfeeding People
Long-Acting Injectable Antiretroviral Drugs for Pregnant and Breastfeeding Women: Current Advances, Challenges, and Future Directions
Assessment of Facility Readiness for PrEP Provision in Antenatal and Postnatal Care Services
Oral PrEP for PBFP Training Package
Key Considerations for Integration of PrEP for Pregnant and Breastfeeding People into National Prevention of Vertical Transmission Polices
No results found.